Anti Viral Agents and Treatments

The Universal Therapeutic Industry at a predicted worth of $1485.02 million in 2013 is expected to reach $1932.8 million by 2018 growing at a CAGR of 5.6%.

Virotherapy is a sub-field of Virology and therapeutics, which uses biotechnology as a means to convert viruses into required therapeutic agents by reprogramming the genome and other metabolic pathways of viruses to treat diseases. There are 3 categories of virotherapy as of now:
1. Anti-cancer oncolytic viruses, 
2. Viral vectors for gene therapy and
3. Viral immunotherapy.

  • Categories in Virotherapy
  • Required therapeutic agents
  • Viral vectors for gene therapy
  • Newly developed therapies for various viruses

Related Conference of Anti Viral Agents and Treatments

October 21-22, 2019

6th World Congress and Expo on Applied Microbiology

Rome, Italy
October 23-24, 2019

2nd Global Experts Meeting on Chronic Diseases

Tokyo, Japan
November 06-07, 2019 |

15th Global Summit on Virology and Microbiology

Yokohama | Japan
November 14-15, 2019

23rd World Congress on Biotechnology

| Holiday Inn Amsterdam - Arena Towers Hoogoorddreef | Amsterdam, Netherlands
December 04-05, 2019

Orthodontics and Prosthodontics

Tokyo, Japan
April 15-16, 2020

23rd World Nursing Education Conference

Tokyo, Japan
June 15-16, 2020

49th World Congress on Microbiology

London, UK
June 24-25, 2020

12th International Virology Summit

Rome, Italy

Anti Viral Agents and Treatments Conference Speakers

Recommended Sessions

Related Journals

Are you interested in